Article Details

Rare Disease Drug Market to See Drastic Growth – Post 2021 : Celgene, Pfizer, Sanofi, Alexion ...

Retrieved on: 2021-02-06 08:37:30

Tags for this article:

Click the tags to see associated articles and topics

Rare Disease Drug Market to See Drastic Growth – Post 2021 : Celgene, Pfizer, Sanofi, Alexion .... View article details on hiswai:

Excerpt

... Alexion Pharmaceuticals, Inc. (United States), Eli Lilly and Company (United States), Novo Nordisk A/S (Denmark), AstraZeneca (United Kingdom), ...

Article found on: neighborwebsj.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up